Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04598828 · ClinicalTrials.gov registry record · NA
Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04598828 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 15 participants.
The verdict
NCT04598828, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is a single-site, double-blinded, randomized clinical trial designed to elucidate mechanism(s) of action for symptomatic benefits observed in Parkinson's disease (PD)
Interventions
- DEVICE Non-invasive brainstem stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-07-06 |
| Est. Completion | 2024-10-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04598828
The ClinicalTrials.gov registry entry for NCT04598828 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive brainstem stimulation is the first listed.
NCT04598828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04598828 about?
NCT04598828 is a clinical study titled "Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease". This study is a single-site, double-blinded, randomized clinical trial designed to elucidate mechanism(s) of action for symptomatic benefits observed in Parkinson's disease (PD)
What is the current status of trial NCT04598828?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2021-07-06. Estimated completion is 2024-10-07.
What interventions are being tested in trial NCT04598828?
The interventions under investigation include: Non-invasive brainstem stimulation (DEVICE).
Who is sponsoring clinical trial NCT04598828?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.